Serveur d'exploration sur la maladie de Parkinson

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Alterations of dopaminergic and noradrenergic innervations in motor cortex in parkinson's disease

Identifieur interne : 001D86 ( Main/Corpus ); précédent : 001D85; suivant : 001D87

Alterations of dopaminergic and noradrenergic innervations in motor cortex in parkinson's disease

Auteurs : Gaspar ; Charles Duyckaerts ; Chantal Alvarez ; France Javoy-Agid ; Brigitte Berger

Source :

RBID : ISTEX:DACF928EDE781033DE18AE3F9A88561AD4E78908

Abstract

The motor areas of the cerebral cortex contain dense dopaminergic and noradrenergic innervation in humans. We looked for changes of these innervations in cases with Parkinson's disease (PD). The density of fibers immunolabeled with tyrosine hydroxylase or dopamine‐beta‐hydroxylase was evaluated in the primary motor, premotor, and prefrontal cortical regions in 6 cases with PD and 7 control cases. Reductions of both noradrenergic and dopaminergic cortical innervations were observed, with similar magnitudes of reduction found in the motor and prefrontal regions of the cortex. Depletion of noradrenergic innervation was diffuse, involving all cortical laminae. Depletion of dopaminergic innervation was laminar specific, with the most significant reductions in layers I and II; reductions in layers V and VI were either less marked (prefrontal cortex) or not detectable (primary motor). The results suggest the existence of two separate mesocortical dopaminergic systems in humans, with the one distributing to upper cortical layers being preferentially involved in PD.

Url:
DOI: 10.1002/ana.410300308

Links to Exploration step

ISTEX:DACF928EDE781033DE18AE3F9A88561AD4E78908

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Alterations of dopaminergic and noradrenergic innervations in motor cortex in parkinson's disease</title>
<author>
<name sortKey="Gaspar" sort="Gaspar" uniqKey="Gaspar" last="Gaspar">Gaspar</name>
<affiliation>
<mods:affiliation>INSERM U 106, Hôpital Salpêtrière, Paris, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Duyckaerts, Charles" sort="Duyckaerts, Charles" uniqKey="Duyckaerts C" first="Charles" last="Duyckaerts">Charles Duyckaerts</name>
<affiliation>
<mods:affiliation>Laboratoire de Neuropathologie Raymond Escourolle, Hôpital Salpêtrière, Paris, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Alvarez, Chantal" sort="Alvarez, Chantal" uniqKey="Alvarez C" first="Chantal" last="Alvarez">Chantal Alvarez</name>
<affiliation>
<mods:affiliation>INSERM U 106, Hôpital Salpêtrière, Paris, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Javoy Gid, France" sort="Javoy Gid, France" uniqKey="Javoy Gid F" first="France" last="Javoy-Agid">France Javoy-Agid</name>
<affiliation>
<mods:affiliation>INSERM U 289, Hôpital Salpêtrière, Paris, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Berger, Brigitte" sort="Berger, Brigitte" uniqKey="Berger B" first="Brigitte" last="Berger">Brigitte Berger</name>
<affiliation>
<mods:affiliation>INSERM U 106, Hôpital Salpêtrière, Paris, France</mods:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:DACF928EDE781033DE18AE3F9A88561AD4E78908</idno>
<date when="1991" year="1991">1991</date>
<idno type="doi">10.1002/ana.410300308</idno>
<idno type="url">https://api.istex.fr/document/DACF928EDE781033DE18AE3F9A88561AD4E78908/fulltext/pdf</idno>
<idno type="wicri:Area/Main/Corpus">001D86</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Alterations of dopaminergic and noradrenergic innervations in motor cortex in parkinson's disease</title>
<author>
<name sortKey="Gaspar" sort="Gaspar" uniqKey="Gaspar" last="Gaspar">Gaspar</name>
<affiliation>
<mods:affiliation>INSERM U 106, Hôpital Salpêtrière, Paris, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Duyckaerts, Charles" sort="Duyckaerts, Charles" uniqKey="Duyckaerts C" first="Charles" last="Duyckaerts">Charles Duyckaerts</name>
<affiliation>
<mods:affiliation>Laboratoire de Neuropathologie Raymond Escourolle, Hôpital Salpêtrière, Paris, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Alvarez, Chantal" sort="Alvarez, Chantal" uniqKey="Alvarez C" first="Chantal" last="Alvarez">Chantal Alvarez</name>
<affiliation>
<mods:affiliation>INSERM U 106, Hôpital Salpêtrière, Paris, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Javoy Gid, France" sort="Javoy Gid, France" uniqKey="Javoy Gid F" first="France" last="Javoy-Agid">France Javoy-Agid</name>
<affiliation>
<mods:affiliation>INSERM U 289, Hôpital Salpêtrière, Paris, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Berger, Brigitte" sort="Berger, Brigitte" uniqKey="Berger B" first="Brigitte" last="Berger">Brigitte Berger</name>
<affiliation>
<mods:affiliation>INSERM U 106, Hôpital Salpêtrière, Paris, France</mods:affiliation>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Annals of Neurology</title>
<title level="j" type="sub">Official Journal of the American Neurological Association and the Child Neurology Society</title>
<title level="j" type="abbrev">Ann Neurol.</title>
<idno type="ISSN">0364-5134</idno>
<idno type="eISSN">1531-8249</idno>
<imprint>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="1991-09">1991-09</date>
<biblScope unit="volume">30</biblScope>
<biblScope unit="issue">3</biblScope>
<biblScope unit="page" from="365">365</biblScope>
<biblScope unit="page" to="374">374</biblScope>
</imprint>
<idno type="ISSN">0364-5134</idno>
</series>
<idno type="istex">DACF928EDE781033DE18AE3F9A88561AD4E78908</idno>
<idno type="DOI">10.1002/ana.410300308</idno>
<idno type="ArticleID">ANA410300308</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0364-5134</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass></textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The motor areas of the cerebral cortex contain dense dopaminergic and noradrenergic innervation in humans. We looked for changes of these innervations in cases with Parkinson's disease (PD). The density of fibers immunolabeled with tyrosine hydroxylase or dopamine‐beta‐hydroxylase was evaluated in the primary motor, premotor, and prefrontal cortical regions in 6 cases with PD and 7 control cases. Reductions of both noradrenergic and dopaminergic cortical innervations were observed, with similar magnitudes of reduction found in the motor and prefrontal regions of the cortex. Depletion of noradrenergic innervation was diffuse, involving all cortical laminae. Depletion of dopaminergic innervation was laminar specific, with the most significant reductions in layers I and II; reductions in layers V and VI were either less marked (prefrontal cortex) or not detectable (primary motor). The results suggest the existence of two separate mesocortical dopaminergic systems in humans, with the one distributing to upper cortical layers being preferentially involved in PD.</div>
</front>
</TEI>
<istex>
<corpusName>wiley</corpusName>
<author>
<json:item>
<name>Dr. Gaspar MD, PhD</name>
<affiliations>
<json:string>INSERM U 106, Hôpital Salpêtrière, Paris, France</json:string>
</affiliations>
</json:item>
<json:item>
<name>Charles Duyckaerts MD, PhD</name>
<affiliations>
<json:string>Laboratoire de Neuropathologie Raymond Escourolle, Hôpital Salpêtrière, Paris, France</json:string>
</affiliations>
</json:item>
<json:item>
<name>Chantal Alvarez</name>
<affiliations>
<json:string>INSERM U 106, Hôpital Salpêtrière, Paris, France</json:string>
</affiliations>
</json:item>
<json:item>
<name>France Javoy‐Agid PhD</name>
<affiliations>
<json:string>INSERM U 289, Hôpital Salpêtrière, Paris, France</json:string>
</affiliations>
</json:item>
<json:item>
<name>Brigitte Berger MD, PhD</name>
<affiliations>
<json:string>INSERM U 106, Hôpital Salpêtrière, Paris, France</json:string>
</affiliations>
</json:item>
</author>
<articleId>
<json:string>ANA410300308</json:string>
</articleId>
<language>
<json:string>eng</json:string>
</language>
<abstract>The motor areas of the cerebral cortex contain dense dopaminergic and noradrenergic innervation in humans. We looked for changes of these innervations in cases with Parkinson's disease (PD). The density of fibers immunolabeled with tyrosine hydroxylase or dopamine‐beta‐hydroxylase was evaluated in the primary motor, premotor, and prefrontal cortical regions in 6 cases with PD and 7 control cases. Reductions of both noradrenergic and dopaminergic cortical innervations were observed, with similar magnitudes of reduction found in the motor and prefrontal regions of the cortex. Depletion of noradrenergic innervation was diffuse, involving all cortical laminae. Depletion of dopaminergic innervation was laminar specific, with the most significant reductions in layers I and II; reductions in layers V and VI were either less marked (prefrontal cortex) or not detectable (primary motor). The results suggest the existence of two separate mesocortical dopaminergic systems in humans, with the one distributing to upper cortical layers being preferentially involved in PD.</abstract>
<qualityIndicators>
<score>6.836</score>
<pdfVersion>1.3</pdfVersion>
<pdfPageSize>576 x 792 pts</pdfPageSize>
<refBibsNative>true</refBibsNative>
<keywordCount>0</keywordCount>
<abstractCharCount>1073</abstractCharCount>
<pdfWordCount>5370</pdfWordCount>
<pdfCharCount>34207</pdfCharCount>
<pdfPageCount>10</pdfPageCount>
<abstractWordCount>153</abstractWordCount>
</qualityIndicators>
<title>Alterations of dopaminergic and noradrenergic innervations in motor cortex in parkinson's disease</title>
<genre>
<json:string>article</json:string>
</genre>
<host>
<volume>30</volume>
<publisherId>
<json:string>ANA</json:string>
</publisherId>
<pages>
<total>10</total>
<last>374</last>
<first>365</first>
</pages>
<issn>
<json:string>0364-5134</json:string>
</issn>
<issue>3</issue>
<subject>
<json:item>
<value>Original Article</value>
</json:item>
</subject>
<genre>
<json:string>Journal</json:string>
</genre>
<language>
<json:string>unknown</json:string>
</language>
<eissn>
<json:string>1531-8249</json:string>
</eissn>
<title>Annals of Neurology</title>
<doi>
<json:string>10.1002/(ISSN)1531-8249</json:string>
</doi>
</host>
<publicationDate>1991</publicationDate>
<copyrightDate>1991</copyrightDate>
<doi>
<json:string>10.1002/ana.410300308</json:string>
</doi>
<id>DACF928EDE781033DE18AE3F9A88561AD4E78908</id>
<fulltext>
<json:item>
<original>true</original>
<mimetype>application/pdf</mimetype>
<extension>pdf</extension>
<uri>https://api.istex.fr/document/DACF928EDE781033DE18AE3F9A88561AD4E78908/fulltext/pdf</uri>
</json:item>
<json:item>
<original>false</original>
<mimetype>application/zip</mimetype>
<extension>zip</extension>
<uri>https://api.istex.fr/document/DACF928EDE781033DE18AE3F9A88561AD4E78908/fulltext/zip</uri>
</json:item>
<istex:fulltextTEI uri="https://api.istex.fr/document/DACF928EDE781033DE18AE3F9A88561AD4E78908/fulltext/tei">
<teiHeader>
<fileDesc>
<titleStmt>
<title level="a" type="main" xml:lang="en">Alterations of dopaminergic and noradrenergic innervations in motor cortex in parkinson's disease</title>
</titleStmt>
<publicationStmt>
<authority>ISTEX</authority>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<availability>
<p>WILEY</p>
</availability>
<date>1991</date>
</publicationStmt>
<sourceDesc>
<biblStruct type="inbook">
<analytic>
<title level="a" type="main" xml:lang="en">Alterations of dopaminergic and noradrenergic innervations in motor cortex in parkinson's disease</title>
<author>
<persName>
<surname>Gaspar</surname>
</persName>
<roleName type="degree">Dr.</roleName>
<note type="correspondence">
<p>Correspondence: INSERM U 106, Batiment de Pédiatrie, Hôpital Salpêtrière, 47, blvd de l'Hôpital, 75651, Paris Cedex 13, France</p>
</note>
<affiliation>INSERM U 106, Hôpital Salpêtrière, Paris, France</affiliation>
</author>
<author>
<persName>
<forename type="first">Charles</forename>
<surname>Duyckaerts</surname>
</persName>
<roleName type="degree">MD, PhD</roleName>
<affiliation>Laboratoire de Neuropathologie Raymond Escourolle, Hôpital Salpêtrière, Paris, France</affiliation>
</author>
<author>
<persName>
<forename type="first">Chantal</forename>
<surname>Alvarez</surname>
</persName>
<affiliation>INSERM U 106, Hôpital Salpêtrière, Paris, France</affiliation>
</author>
<author>
<persName>
<forename type="first">France</forename>
<surname>Javoy‐Agid</surname>
</persName>
<roleName type="degree">PhD</roleName>
<affiliation>INSERM U 289, Hôpital Salpêtrière, Paris, France</affiliation>
</author>
<author>
<persName>
<forename type="first">Brigitte</forename>
<surname>Berger</surname>
</persName>
<roleName type="degree">MD, PhD</roleName>
<affiliation>INSERM U 106, Hôpital Salpêtrière, Paris, France</affiliation>
</author>
</analytic>
<monogr>
<title level="j">Annals of Neurology</title>
<title level="j" type="sub">Official Journal of the American Neurological Association and the Child Neurology Society</title>
<title level="j" type="abbrev">Ann Neurol.</title>
<idno type="pISSN">0364-5134</idno>
<idno type="eISSN">1531-8249</idno>
<idno type="DOI">10.1002/(ISSN)1531-8249</idno>
<imprint>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="1991-09"></date>
<biblScope unit="volume">30</biblScope>
<biblScope unit="issue">3</biblScope>
<biblScope unit="page" from="365">365</biblScope>
<biblScope unit="page" to="374">374</biblScope>
</imprint>
</monogr>
<idno type="istex">DACF928EDE781033DE18AE3F9A88561AD4E78908</idno>
<idno type="DOI">10.1002/ana.410300308</idno>
<idno type="ArticleID">ANA410300308</idno>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<creation>
<date>1991</date>
</creation>
<langUsage>
<language ident="en">en</language>
</langUsage>
<abstract xml:lang="en">
<p>The motor areas of the cerebral cortex contain dense dopaminergic and noradrenergic innervation in humans. We looked for changes of these innervations in cases with Parkinson's disease (PD). The density of fibers immunolabeled with tyrosine hydroxylase or dopamine‐beta‐hydroxylase was evaluated in the primary motor, premotor, and prefrontal cortical regions in 6 cases with PD and 7 control cases. Reductions of both noradrenergic and dopaminergic cortical innervations were observed, with similar magnitudes of reduction found in the motor and prefrontal regions of the cortex. Depletion of noradrenergic innervation was diffuse, involving all cortical laminae. Depletion of dopaminergic innervation was laminar specific, with the most significant reductions in layers I and II; reductions in layers V and VI were either less marked (prefrontal cortex) or not detectable (primary motor). The results suggest the existence of two separate mesocortical dopaminergic systems in humans, with the one distributing to upper cortical layers being preferentially involved in PD.</p>
</abstract>
<textClass>
<keywords scheme="Journal Subject">
<list>
<head>article category</head>
<item>
<term>Original Article</term>
</item>
</list>
</keywords>
</textClass>
</profileDesc>
<revisionDesc>
<change when="1990-12-12">Received</change>
<change when="1991-02-12">Registration</change>
<change when="1991-09">Published</change>
</revisionDesc>
</teiHeader>
</istex:fulltextTEI>
<json:item>
<original>false</original>
<mimetype>text/plain</mimetype>
<extension>txt</extension>
<uri>https://api.istex.fr/document/DACF928EDE781033DE18AE3F9A88561AD4E78908/fulltext/txt</uri>
</json:item>
</fulltext>
<metadata>
<istex:metadataXml wicri:clean="Wiley, elements deleted: body">
<istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration>
<istex:document>
<component version="2.0" type="serialArticle" xml:lang="en">
<header>
<publicationMeta level="product">
<publisherInfo>
<publisherName>Wiley Subscription Services, Inc., A Wiley Company</publisherName>
<publisherLoc>Hoboken</publisherLoc>
</publisherInfo>
<doi registered="yes">10.1002/(ISSN)1531-8249</doi>
<issn type="print">0364-5134</issn>
<issn type="electronic">1531-8249</issn>
<idGroup>
<id type="product" value="ANA"></id>
</idGroup>
<titleGroup>
<title type="main" xml:lang="en" sort="ANNALS OF NEUROLOGY">Annals of Neurology</title>
<title type="subtitle">Official Journal of the American Neurological Association and the Child Neurology Society</title>
<title type="short">Ann Neurol.</title>
</titleGroup>
</publicationMeta>
<publicationMeta level="part" position="30">
<doi origin="wiley" registered="yes">10.1002/ana.v30:3</doi>
<numberingGroup>
<numbering type="journalVolume" number="30">30</numbering>
<numbering type="journalIssue">3</numbering>
</numberingGroup>
<coverDate startDate="1991-09">September 1991</coverDate>
</publicationMeta>
<publicationMeta level="unit" type="article" position="8" status="forIssue">
<doi origin="wiley" registered="yes">10.1002/ana.410300308</doi>
<idGroup>
<id type="unit" value="ANA410300308"></id>
</idGroup>
<countGroup>
<count type="pageTotal" number="10"></count>
</countGroup>
<titleGroup>
<title type="articleCategory">Original Article</title>
<title type="tocHeading1">Original Articles</title>
</titleGroup>
<copyright ownership="thirdParty">Copyright © 1991 American Neurological Association</copyright>
<eventGroup>
<event type="manuscriptReceived" date="1990-12-12"></event>
<event type="manuscriptRevised" date="1991-02-12"></event>
<event type="manuscriptAccepted" date="1991-02-12"></event>
<event type="firstOnline" date="2004-10-08"></event>
<event type="publishedOnlineFinalForm" date="2004-10-08"></event>
<event type="xmlConverted" agent="Converter:JWSART34_TO_WML3G version:2.3.1 mode:FullText source:HeaderRef result:HeaderRef" date="2010-02-23"></event>
<event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-01-03"></event>
<event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-14"></event>
</eventGroup>
<numberingGroup>
<numbering type="pageFirst">365</numbering>
<numbering type="pageLast">374</numbering>
</numberingGroup>
<correspondenceTo>INSERM U 106, Batiment de Pédiatrie, Hôpital Salpêtrière, 47, blvd de l'Hôpital, 75651, Paris Cedex 13, France</correspondenceTo>
<linkGroup>
<link type="toTypesetVersion" href="file:ANA.ANA410300308.pdf"></link>
</linkGroup>
</publicationMeta>
<contentMeta>
<countGroup>
<count type="figureTotal" number="2"></count>
<count type="tableTotal" number="4"></count>
<count type="referenceTotal" number="61"></count>
</countGroup>
<titleGroup>
<title type="main" xml:lang="en">Alterations of dopaminergic and noradrenergic innervations in motor cortex in parkinson's disease</title>
<title type="short" xml:lang="en">Dopaminergic and Noradrenergic Innervations of Cortex in PD</title>
</titleGroup>
<creators>
<creator xml:id="au1" creatorRole="author" affiliationRef="#af1" corresponding="yes">
<personName>
<honorifics>Dr.</honorifics>
<givenNames>Patricia</givenNames>
<familyName>Gaspar</familyName>
<degrees>MD, PhD</degrees>
</personName>
</creator>
<creator xml:id="au2" creatorRole="author" affiliationRef="#af2">
<personName>
<givenNames>Charles</givenNames>
<familyName>Duyckaerts</familyName>
<degrees>MD, PhD</degrees>
</personName>
</creator>
<creator xml:id="au3" creatorRole="author" affiliationRef="#af1">
<personName>
<givenNames>Chantal</givenNames>
<familyName>Alvarez</familyName>
</personName>
</creator>
<creator xml:id="au4" creatorRole="author" affiliationRef="#af3">
<personName>
<givenNames>France</givenNames>
<familyName>Javoy‐Agid</familyName>
<degrees>PhD</degrees>
</personName>
</creator>
<creator xml:id="au5" creatorRole="author" affiliationRef="#af1">
<personName>
<givenNames>Brigitte</givenNames>
<familyName>Berger</familyName>
<degrees>MD, PhD</degrees>
</personName>
</creator>
</creators>
<affiliationGroup>
<affiliation xml:id="af1" countryCode="FR" type="organization">
<unparsedAffiliation>INSERM U 106, Hôpital Salpêtrière, Paris, France</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af2" countryCode="FR" type="organization">
<unparsedAffiliation>Laboratoire de Neuropathologie Raymond Escourolle, Hôpital Salpêtrière, Paris, France</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af3" countryCode="FR" type="organization">
<unparsedAffiliation>INSERM U 289, Hôpital Salpêtrière, Paris, France</unparsedAffiliation>
</affiliation>
</affiliationGroup>
<abstractGroup>
<abstract type="main" xml:lang="en">
<title type="main">Abstract</title>
<p>The motor areas of the cerebral cortex contain dense dopaminergic and noradrenergic innervation in humans. We looked for changes of these innervations in cases with Parkinson's disease (PD). The density of fibers immunolabeled with tyrosine hydroxylase or dopamine‐beta‐hydroxylase was evaluated in the primary motor, premotor, and prefrontal cortical regions in 6 cases with PD and 7 control cases. Reductions of both noradrenergic and dopaminergic cortical innervations were observed, with similar magnitudes of reduction found in the motor and prefrontal regions of the cortex. Depletion of noradrenergic innervation was diffuse, involving all cortical laminae. Depletion of dopaminergic innervation was laminar specific, with the most significant reductions in layers I and II; reductions in layers V and VI were either less marked (prefrontal cortex) or not detectable (primary motor). The results suggest the existence of two separate mesocortical dopaminergic systems in humans, with the one distributing to upper cortical layers being preferentially involved in PD.</p>
</abstract>
</abstractGroup>
</contentMeta>
</header>
</component>
</istex:document>
</istex:metadataXml>
<mods version="3.6">
<titleInfo lang="en">
<title>Alterations of dopaminergic and noradrenergic innervations in motor cortex in parkinson's disease</title>
</titleInfo>
<titleInfo type="abbreviated" lang="en">
<title>Dopaminergic and Noradrenergic Innervations of Cortex in PD</title>
</titleInfo>
<titleInfo type="alternative" contentType="CDATA" lang="en">
<title>Alterations of dopaminergic and noradrenergic innervations in motor cortex in parkinson's disease</title>
</titleInfo>
<name type="personal">
<namePart type="termsOfAddress">Dr.</namePart>
<namePart type="family">Gaspar</namePart>
<namePart type="termsOfAddress">MD, PhD</namePart>
<affiliation>INSERM U 106, Hôpital Salpêtrière, Paris, France</affiliation>
<description>Correspondence: INSERM U 106, Batiment de Pédiatrie, Hôpital Salpêtrière, 47, blvd de l'Hôpital, 75651, Paris Cedex 13, France</description>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Charles</namePart>
<namePart type="family">Duyckaerts</namePart>
<namePart type="termsOfAddress">MD, PhD</namePart>
<affiliation>Laboratoire de Neuropathologie Raymond Escourolle, Hôpital Salpêtrière, Paris, France</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Chantal</namePart>
<namePart type="family">Alvarez</namePart>
<affiliation>INSERM U 106, Hôpital Salpêtrière, Paris, France</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">France</namePart>
<namePart type="family">Javoy‐Agid</namePart>
<namePart type="termsOfAddress">PhD</namePart>
<affiliation>INSERM U 289, Hôpital Salpêtrière, Paris, France</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Brigitte</namePart>
<namePart type="family">Berger</namePart>
<namePart type="termsOfAddress">MD, PhD</namePart>
<affiliation>INSERM U 106, Hôpital Salpêtrière, Paris, France</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<typeOfResource>text</typeOfResource>
<genre type="article" displayLabel="article"></genre>
<originInfo>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<place>
<placeTerm type="text">Hoboken</placeTerm>
</place>
<dateIssued encoding="w3cdtf">1991-09</dateIssued>
<dateCaptured encoding="w3cdtf">1990-12-12</dateCaptured>
<dateValid encoding="w3cdtf">1991-02-12</dateValid>
<copyrightDate encoding="w3cdtf">1991</copyrightDate>
</originInfo>
<language>
<languageTerm type="code" authority="rfc3066">en</languageTerm>
<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</language>
<physicalDescription>
<internetMediaType>text/html</internetMediaType>
<extent unit="figures">2</extent>
<extent unit="tables">4</extent>
<extent unit="references">61</extent>
</physicalDescription>
<abstract lang="en">The motor areas of the cerebral cortex contain dense dopaminergic and noradrenergic innervation in humans. We looked for changes of these innervations in cases with Parkinson's disease (PD). The density of fibers immunolabeled with tyrosine hydroxylase or dopamine‐beta‐hydroxylase was evaluated in the primary motor, premotor, and prefrontal cortical regions in 6 cases with PD and 7 control cases. Reductions of both noradrenergic and dopaminergic cortical innervations were observed, with similar magnitudes of reduction found in the motor and prefrontal regions of the cortex. Depletion of noradrenergic innervation was diffuse, involving all cortical laminae. Depletion of dopaminergic innervation was laminar specific, with the most significant reductions in layers I and II; reductions in layers V and VI were either less marked (prefrontal cortex) or not detectable (primary motor). The results suggest the existence of two separate mesocortical dopaminergic systems in humans, with the one distributing to upper cortical layers being preferentially involved in PD.</abstract>
<relatedItem type="host">
<titleInfo>
<title>Annals of Neurology</title>
<subTitle>Official Journal of the American Neurological Association and the Child Neurology Society</subTitle>
</titleInfo>
<titleInfo type="abbreviated">
<title>Ann Neurol.</title>
</titleInfo>
<genre type="Journal">journal</genre>
<subject>
<genre>article category</genre>
<topic>Original Article</topic>
</subject>
<identifier type="ISSN">0364-5134</identifier>
<identifier type="eISSN">1531-8249</identifier>
<identifier type="DOI">10.1002/(ISSN)1531-8249</identifier>
<identifier type="PublisherID">ANA</identifier>
<part>
<date>1991</date>
<detail type="volume">
<caption>vol.</caption>
<number>30</number>
</detail>
<detail type="issue">
<caption>no.</caption>
<number>3</number>
</detail>
<extent unit="pages">
<start>365</start>
<end>374</end>
<total>10</total>
</extent>
</part>
</relatedItem>
<identifier type="istex">DACF928EDE781033DE18AE3F9A88561AD4E78908</identifier>
<identifier type="DOI">10.1002/ana.410300308</identifier>
<identifier type="ArticleID">ANA410300308</identifier>
<accessCondition type="use and reproduction" contentType="copyright">Copyright © 1991 American Neurological Association</accessCondition>
<recordInfo>
<recordContentSource>WILEY</recordContentSource>
<recordOrigin>Wiley Subscription Services, Inc., A Wiley Company</recordOrigin>
</recordInfo>
</mods>
</metadata>
<serie></serie>
</istex>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001D86 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 001D86 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Corpus
   |type=    RBID
   |clé=     ISTEX:DACF928EDE781033DE18AE3F9A88561AD4E78908
   |texte=   Alterations of dopaminergic and noradrenergic innervations in motor cortex in parkinson's disease
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024